Searchable abstracts of presentations at key conferences in endocrinology

ea0025cg1.1 | (1) | SFEBES2011

Pituitary apoplexy new society guidelines for treatment

Wass John , Kumar Senthil , Reddy Narendra , Vanderpump Mark , Baldeweg Stephanie

The guidelines for the treatment of pituitary apoplexy have now been published in Clinical Endocrinology (Clin Endocrinol 2011 Jan;74(1):9–20). These resulted from a group set up during the London pituitary multidisciplinary meeting.Classical pituitary apoplexy is a medical emergency and rapid replacement with hydrocortisone maybe life saving. It is a clinical syndrome characterised by the sudden onset of headache, vomiting, visual imp...

ea0024p35 | (1) | BSPED2010

NAFLD in type 1 DM: a report of 2 cases

Kumar P , Ghatak A , Blair J C , Didi M , Paul P

Introduction: Non-alcoholic steatohepatitis (NASH) is part of the spectrum of non-alcoholic fatty liver disease (NAFLD). NASH commonly occurs in patients with type 2 DM and is less recognised in type 1 DM. The natural history of NASH in adult patients suggests potential development of progressive fibrosis and cirrhosis. However, secondary glycogenosis, commonly occurs in type 1 DM, is reversible when good glycaemic control is achieved, but may be misidentified as NASH b...

ea0023p15 | (1) | BSPED2009

Growth hormone therapy in the treatment of short stature in cardio-facio-cutaneous syndrome

Kumar Priya , Fryer Alan , Ellison Julie , Blair Joanne

Background: The term “neuro-cardio-facial-cutaneous (NCFC) syndrome” describes a group of phenotypically overlapping syndromes that result from germline mutations in genes of the RAS-MAPKinase pathway. This pathway plays a role in growth factor signalling and short stature is a consistent feature of NCFC syndromes. This diagnostic group includes Noonan syndrome (NS) and cardio-facio-cutaneous (CFC) syndrome. Growth hormone (GH) has been used with good effect in NS. T...

ea0019p339 | Thyroid | SFEBES2009

Association between thyroid hormones, insulin resistance and metabolic syndrome

Kumar KVS Hari , Reddy CV K , Raghunath M , Modi KD

Introduction: Recent reports suggest that thyroid hormones are independently associated with components of metabolic syndrome. We studied the association between thyroid hormones, insulin resistance and components of metabolic syndrome in euthyroid overweight or obese individuals.Methods: A total of 45 overweight or obese women with no past history of thyroid disease or diabetes mellitus were studied. Body fat was estimated by bio-impedance method and wa...

ea0019p344 | Thyroid | SFEBES2009

Carbimazole induced hearing loss

Raja UY , Warner D , Possamai V , Kumar A , Barton D

Case: In April 2008, a 68-year-old male was referred to the endocrine clinic with symptoms of hyperthyroidism and was prescribed carbimazole 20 mg daily. A week later, he developed sudden onset dizziness, together with reduced hearing in his left ear and associated tinnitus. Similar symptoms developed in his right ear shortly thereafter. Seven weeks after starting carbimazole, he attended the ENT outpatient clinic with severe vertigo, tinnitus and bilateral hearing loss. Otosc...

ea0017p13 | (1) | BSPED2008

Short-term height gain in boys with constitutional delay of growth and puberty treated with testosterone esters or enantate

Gardner C , Kumar P , Banerjee I , Didi M , Blair J

In boys with constitutional delay of growth and puberty (CDGP), puberty may be induced with a short course of testosterone, either as esters or enantate injections. While both types of testosterone are known to be effective in inducing puberty, there are no studies comparing their efficacies. We have compared height gain, a quantitative marker of puberty, between boys treated with a short course of testosterone esters and enantate injections in a retrospective, observational s...

ea0015p53 | Clinical practice/governance and case reports | SFEBES2008

Hypogonadotropic hypogonadism: a consequence of Chiari-I malformation

Kumar Sampath Satish , Chumas Paul , Peckham Daniel , Murray Robert

A 24-year-old women (wt 63 kg, BMI 23) presented with history of secondary amenorrhea. Menarche occurred at age 16 years and was followed by a regular cycle (7/35). She started the combined oral contraceptive pill (OCP) at 18 years of age for menorrhagia and stopped this 16 months before her presentation, before undergoing elective surgery. Four months after discontinuing the OCP she experienced a single episode of PV bleeding, but otherwise remained amenorrhoeic. Past history...

ea0015p194 | Growth and development | SFEBES2008

A case of Gorlin-Goltz syndrome with delayed puberty

Muralidhara Koteshwara , Kumar Jesse , Barnes Dennis , Goulden Peter

We report a case of a 20-year-old male with a clinical profile of Gorlin-Goltz syndrome with delayed puberty. This 20-year-old man had learning disablitiy, macrocephaly and multiple jaw cysts. His other clinical features included agenesis of the carpus callosum, obesity and multiple cutaneous lesions suggestive of angiolipomata. His pubertal development was delayed although a LHRH test done at the age of 16 showed a normal response. Radiological features included macrocephaly,...

ea0015p256 | Pituitary | SFEBES2008

Post-operative hypogonadotrophic hypogonadism

Chaudry Rahat , Sellers Daniel , Goulden Peter , Barnes Dennis , Kumar Jesse

This 55-year-old gentleman presented to endocrine clinic following an episode of septicaemic shock complicating benign prostatic surgery one year previously. He subsequently developed symptoms of lethargy, palpitations, lightheadedness, peripheral weakness and loss of libido, which had developed after this episode. Routine biochemistry and ambulatory electrocardiography measurements were normal.Endocrine testing revealed:: - Undetectable gonadotrophins (...

ea0015p356 | Thyroid | SFEBES2008

The follow up of radioiodine treated hyperthyroid patients: the Bradford experience

Satish Kumar Sampath , King Rhodric , Wright Diane , Peacey Steve

There is a relative lack of data regarding the timing and in particular the severity of hypothyroidism post Radioiodine (RI). We retrospectively examined the timing and severity of hypothyroidism following RI in 213 patients, in relation to ‘target’ and actual follow up appointments, and the introduction of a nurse-led follow-up clinic. Hypothyroidism was defined as persistent elevation of TSH – mild (TSH 6.1–10 mU/l), moderate (TSH 10.1–50 mU/l) and s...